Cervical endometrioid adenocarcinoma

Summary

Cervical endometrioid adenocarcinoma (MONDO:0003665) is a disease. A subtype of endometrioid adenocarcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	cervical endometrioid adenocarcinoma
Mondo ID	MONDO:0003665
EFO	EFO:1000164
DOID	DOID:5830
NCIT	C6343
UMLS	C1332913
MedGen	272450
GARD	0023611
Anatomy (UBERON)	UBERON:0000002
Is cancer (heuristic)	no

Also known as: cervical endometrioid adenocarcinoma · cervical endometrioid carcinoma · cervix endometrioid adenocarcinoma · cervix endometrioid carcinoma · cervix uteri endometrioid adenocarcinoma · cervix uteri endometrioid carcinoma · endometrioid adenocarcinoma of cervix · endometrioid adenocarcinoma of cervix uteri · endometrioid adenocarcinoma of the cervix · endometrioid adenocarcinoma of the cervix uteri · endometrioid adenocarcinoma of the uterine cervix · endometrioid adenocarcinoma of uterine cervix · endometrioid carcinoma of cervix · endometrioid carcinoma of cervix uteri · endometrioid carcinoma of the cervix · endometrioid carcinoma of the cervix uteri · endometrioid carcinoma of the uterine cervix · endometrioid carcinoma of uterine cervix · uterine cervix endometrioid adenocarcinoma · uterine cervix endometrioid carcinoma

Data availability: 1 cell line.

Disease family

This is a subtype of endometrioid adenocarcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › reproductive system cancer › female reproductive organ cancer › endometrioid adenocarcinoma › cervical endometrioid adenocarcinoma

Related subtypes (5): fallopian tube endometrioid adenocarcinoma, stage I endometrioid carcinoma, stage II endometrioid carcinoma, endometrial endometrioid adenocarcinoma, ovarian endometrioid adenocarcinoma

Subtypes (1): uterine ligament endometrioid adenocarcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.